Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report

Immunotherapy alone or chemo-immunotherapy has recently been recommended for treating advanced lung carcinoma in patients without driver mutations. However, the efficacy of immunotherapy and molecular mechanism in large-cell lung cancer (LCLC) remains unclear. Here, we reported a rare case of multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhilin, Zhang, Hong, Xiao, Yajie, Wang, Rui, Zhang, Liping, Huang, Chenglu, Cao, Yu, Sun, Chao, Zhao, Yongtian, Lin, Hanqing, Wu, Dongfang, Wang, Tianhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173040/
https://www.ncbi.nlm.nih.gov/pubmed/34094914
http://dx.doi.org/10.3389/fonc.2021.633446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173040/
https://www.ncbi.nlm.nih.gov/pubmed/34094914
http://dx.doi.org/10.3389/fonc.2021.633446

Ejemplares similares